Universitaetsklinikum Heidelberg Nationales Centrum fuer Tumorerkrankungen

Heidelberg 69120

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-resistant Prostate Neoplasms, Primary Sclerosing Cholangitis

Studies at this site

• A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. — Running, not enrolling